EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

How safe is cytisinicline as a first-line smoking cessation treatment during pregnancy and lactation?

Maria Vlachou, Giannoula Kyrkou, Angeliki Bakou, Victoria Vivilaki, Athina Diamanti

Public Health and Toxicology · 30.06.2026 · 6 (2) · 1-3

DOI: 10.18332/pht/225402 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Public Health and Toxicology, online erschienen am 30.06.2026. Verfasst von Maria Vlachou und 4 weiteren Autor:innen. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

bodies differ in their recommendations: some suggest that NRT may be used cautiously under medical supervision when behavioral strategies alone are insufficient, whereas others conclude that current evidence is insufficient to recommend for or against its routine use during pregnancy

Zitieren

APA

Vlachou, M., Kyrkou, G., Bakou, A., Vivilaki, V., & Diamanti, A. (2026). How safe is cytisinicline as a first-line smoking cessation treatment during pregnancy and lactation?. Public Health and Toxicology, 6(2), 1-3. https://doi.org/10.18332/pht/225402

Vancouver

Vlachou M, Kyrkou G, Bakou A, Vivilaki V, Diamanti A. How safe is cytisinicline as a first-line smoking cessation treatment during pregnancy and lactation?. Public Health and Toxicology. 2026;6(2):1-3. doi:10.18332/pht/225402

BibTeX
@article{Vlachou2026,
  author = {Vlachou, Maria and Kyrkou, Giannoula and Bakou, Angeliki and Vivilaki, Victoria and Diamanti, Athina},
  title = {How safe is cytisinicline as a first-line smoking cessation treatment during pregnancy and lactation?},
  journal = {Public Health and Toxicology},
  year = {2026},
  volume = {6},
  number = {2},
  pages = {1--3},
  doi = {10.18332/pht/225402}
}
Kostenlos starten →